Status:
WITHDRAWN
Assisted Fluid Management in Patients Undergoing Major Abdominal and Orthopedic Surgery
Lead Sponsor:
Erasme University Hospital
Collaborating Sponsors:
APHP
Conditions:
Goal Directed Fluid Therapy
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
This study will compare a group of patients managed with a manual GDFT protocol (using the EV1000 monitoring device; Edwards Lifesciences, Irvine, USA) to a group of patients managed using a decision ...
Detailed Description
Many trials have indicated that goal-directed fluid therapy (GDFT) strategies may benefit high-risk surgical patients but these strategies are infrequently implemented. It has also been shown that wit...
Eligibility Criteria
Inclusion
- All adult patients in the operating room scheduled for a major abdominal \& orthopedic surgery requiring a cardiac output monitoring (EV1000).
- Written informed consent received before surgery.
Exclusion
- Minor Patients.
- No french speaking.
- Atrial fibrillation or severe arythmia.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03779373
Start Date
April 1 2019
End Date
July 30 2020
Last Update
May 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Joosten Alexandre
Paris, Kremlin Bicetre, France, 94270